Repligen Patents – Insights & Stats

Repligen has a total of 843 patents globally, out of which 366 have been granted. Of these 843 patents, more than 52% patents are active. United States of America is where Repligen has filed the maximum number of patents, followed by Europe and Australia. Parallelly, United States of America seems to be the main focused R&D centre of Repligen.

Repligen was founded in the year 1981 by Paul Schimmel. The Company provides bioprocessing technologies and solutions used in the process of manufacturing biologic drugs. As of December 2022, Repligen has a market cap of $9.39 Billion.

Do read about some of the most popular patents of Repligen which have been covered by us in this article and also you can find Repligen patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Repligen patent portfolio.

How many patents does Repligen have?

Repligen has a total of 843 patents globally. These patents belong to 227 unique patent families. Out of 843 patents, 441 patents are active.

How Many Patents did Repligen File Every Year?

Repligen Patent Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantRepligen Applications FiledRepligen Patents Granted
20224047
20212630
20209027
20198413
20186021
20174417
2016306
2015298
20142210
2013202
2012198
2011177

How many Repligen patents are Alive/Dead?

Repligen Patent Portfolio

How Many Patents did Repligen File in Different Countries?

Repligen Worldwide Patent Filing

Countries in which Repligen File Patents

CountriesNo. of Patents
United States Of America183
Europe97
Australia72
Japan65
Korea (South)56
Canada46
Germany41
India32
Singapore28
China26
Austria17
Hong Kong (S.A.R.)11
Sweden11
France10
Spain9
Poland9
Russia7
Mexico6
New Zealand6
Israel5
Indonesia4
Norway4
Brazil3
Denmark3
Portugal2
Turkey2
South Africa2
Switzerland1
United Kingdom1
Hungary1
Bulgaria1
Yugoslavia/Serbia and Montenegro1
Egypt1
Italy1
Malaysia1

Where are Research Centres of Repligen Patents Located?

Research Centres of Repligen Patents

10 Best Repligen Patents

US6544424B1 is the most popular patent in the Repligen portfolio. It has received 386 citations so far from companies like General Electric Company, Millipore Corporation, Kaneka Corporation.

Below is the list of 10 most cited patents of Repligen:

Publication NumberCitation Count
US6544424B1386
US6444792B1227
US6750334B1106
US6349835B180
US6498143B173
US6790825B267
US7091182B266
US20070138082A147
WO2012118782A145
USD472931S141

What are Repligen key innovation segments?

What Technologies are Covered by Repligen?

The chart below distributes patents filed by Repligen in different countries on the basis of the technology protected in patents. It also represents the markets where Repligen thinks it’s important to protect particular technology inventions.

R&D Focus: How has Repligen search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Repligen?

Related Articles

Leave a Comment

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.